Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael V Holmes

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
International Journal of Epidemiology|December 13, 2019
Polygenic risk scores and the prediction of common diseasesMika Ala-Korpela, Michael V Holmes
Clinical Chemistry|January 30, 2019
Can Mendelian Randomization Shift into Reverse Gear?Michael V Holmes, George Davey Smith
Nature Reviews. Cardiology|February 1, 2019
What is 'LDL cholesterol'?Michael V Holmes, Mika Ala-Korpela
Nature Reviews. Cardiology|October 6, 2017
Dyslipidaemia: Revealing the effect of CETP inhibition in cardiovascular diseaseMichael V Holmes, George Davey Smith
Molecular Psychiatry|March 10, 2018
Problems in interpreting and using GWAS of conditional phenotypes illustrated by 'alcohol GWAS'Michael V Holmes, George Davey Smith
Heart (British Cardiac Society)|June 10, 2017
Mendelian randomisation in cardiovascular research: an introduction for cliniciansDerrick A Bennett, Michael V Holmes
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2015
Deciphering the Causal Role of sPLA2s and Lp-PLA2 in Coronary Heart DiseasePhilippa J Talmud, Michael V Holmes
The Lancet. Diabetes & Endocrinology|November 25, 2018
Research digest: genetics in cardiometabolic diseaseNaveed Sattar, Michael V Holmes, David Preiss
Journal of the American College of Cardiology|February 2, 2019
Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the WeekJane Armitage, Michael V Holmes, David Preiss
The Lancet. Rheumatology|October 5, 2020
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19Jonas Bovijn, Cecilia M Lindgren, Michael V Holmes
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
International Journal of Epidemiology|December 13, 2019
Polygenic risk scores and the prediction of common diseasesMika Ala-Korpela, Michael V Holmes
Clinical Chemistry|January 30, 2019
Can Mendelian Randomization Shift into Reverse Gear?Michael V Holmes, George Davey Smith
Nature Reviews. Cardiology|February 1, 2019
What is 'LDL cholesterol'?Michael V Holmes, Mika Ala-Korpela
Nature Reviews. Cardiology|October 6, 2017
Dyslipidaemia: Revealing the effect of CETP inhibition in cardiovascular diseaseMichael V Holmes, George Davey Smith
Molecular Psychiatry|March 10, 2018
Problems in interpreting and using GWAS of conditional phenotypes illustrated by 'alcohol GWAS'Michael V Holmes, George Davey Smith
Heart (British Cardiac Society)|June 10, 2017
Mendelian randomisation in cardiovascular research: an introduction for cliniciansDerrick A Bennett, Michael V Holmes
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2015
Deciphering the Causal Role of sPLA2s and Lp-PLA2 in Coronary Heart DiseasePhilippa J Talmud, Michael V Holmes
The Lancet. Diabetes & Endocrinology|November 25, 2018
Research digest: genetics in cardiometabolic diseaseNaveed Sattar, Michael V Holmes, David Preiss
Journal of the American College of Cardiology|February 2, 2019
Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the WeekJane Armitage, Michael V Holmes, David Preiss
The Lancet. Rheumatology|October 5, 2020
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19Jonas Bovijn, Cecilia M Lindgren, Michael V Holmes
Pageof 22